After researchers performed CYP21A2 genotyping at a mean age of 3.4 years for 33 children who continued to have elevated serum 17OHP levels without a clinical diagnosis of CAH, one had a genotype consistent with SV-CAH.16 This evidence concerns the gene CYP21A2 and congenital adrenal hyperplasia.